Rothermund Lars, Nierhaus Marc, Fialkowski Olaf, Freese Florian, Ibscher Ricarda, Mieschel Susanne, Kossmehl Peter, Grimm Daniela, Wehland Markus, Kreutz Reinhold
Medizinische Klinik IV, Endokrinologie und Nephrologie, Charité Universitätsmedizin Berlin, Berlin, Germany.
J Hypertens. 2006 Sep;24(9):1857-64. doi: 10.1097/01.hjh.0000242411.50536.b9.
Low nephron number may represent a major determinant of human primary hypertension in adult life. This hypothesis is supported by a genetic rat model, namely the Munich-Wistar-Frömter (MWF) rat, which demonstrates an inherited deficit in nephron number and the development of spontaneous hypertension. Insulin-like growth factor (IGF) I and II exert endocrine and paracrine effects that are required for normal growth and nephron development. We tested the hypothesis that low nephron number is already present during fetal development, and the expression pattern of important molecules of the IGF system is altered in MWF rat during the critical period of kidney development.
We compared MWF and normal Wistar rats during nephrogenesis at day 19 of fetal development (E19) and adult rats at postnatal day 100 (D100). Histomorphometric analysis was performed by stereological methods. Quantitative messenger RNA and protein expression was determined by real-time polymerase chain reaction and enzyme-linked immunosorbent assay.
At E19, glomerular density (-32%) and hepatic mRNA (-48%) and protein (-18%) expression of IGF-I were decreased (P < 0.05, respectively), whereas renal mRNA expression of IGF-II receptor (+52%) and IGF binding protein 3 (+113%) were increased in MWF compared with Wistar rats (P < 0.05, respectively). Systolic blood pressure, urinary albumin excretion, and mean glomerular area were significantly elevated in MWF compared with Wistar rats at D100 (P < 0.05, respectively).
The fetal expression of IGF system molecules in the MWF rat model points towards a link between the decreased availability of active IGF-I and IGF-II and the fetal development of low nephron number, with manifestation of genetic hypertension in adult life.
低肾单位数量可能是成人原发性高血压的主要决定因素。这一假说得到了一种遗传性大鼠模型——慕尼黑-威斯塔-弗勒姆特(MWF)大鼠的支持,该模型显示肾单位数量存在遗传性缺陷并会发展为自发性高血压。胰岛素样生长因子(IGF)I和II发挥内分泌和旁分泌作用,这些作用是正常生长和肾单位发育所必需的。我们检验了这样一个假说,即低肾单位数量在胎儿发育期间就已存在,并且在肾发育的关键时期,MWF大鼠中IGF系统重要分子的表达模式会发生改变。
我们比较了胎儿发育第19天(E19)肾发生期的MWF大鼠和正常威斯塔大鼠,以及出生后第100天(D100)的成年大鼠。通过体视学方法进行组织形态计量分析。通过实时聚合酶链反应和酶联免疫吸附测定法测定信使核糖核酸和蛋白质的定量表达。
在E19时,与威斯塔大鼠相比,MWF大鼠的肾小球密度(-32%)、肝脏中IGF-I的信使核糖核酸(-48%)和蛋白质(-18%)表达降低(分别为P < 0.05),而肾脏中IGF-II受体(+52%)和IGF结合蛋白3(+113%)的信使核糖核酸表达增加(分别为P < 0.05)。与威斯塔大鼠相比,在D100时MWF大鼠的收缩压、尿白蛋白排泄量和平均肾小球面积显著升高(分别为P < 0.05)。
MWF大鼠模型中IGF系统分子的胎儿期表达表明,活性IGF-I和IGF-II可用性降低与低肾单位数量的胎儿发育之间存在联系,并在成年后表现为遗传性高血压。